Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1 R01 HL130056-01)
Received: 13 December 2019
Accepted: 1 April 2020
First Online: 12 May 2020
: All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Columbia University.
: Not applicable
: Joseph Backer is the CEO of SibTech, a bioengineering company that developed and manufactures [<sup>99m</sup>Tc]DOTA-PEG-scVEGF.